Skip to content
777 Sourcing.

Capability

mammalian cell culture

Suppliers
3
States & provinces
3
Countries
1

3 mammalian cell culture suppliers across 3 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AVID BIOSERVICES INC

TUSTIN, CA

Avid Bioservices is a U.S.-based biologics CDMO providing integrated mammalian cell culture process development, analytical development, formulation development, and CGMP biologics manufacturing from DNA to IND to commercial supply. It operates FDA-inspected CGMP facilities in California, including an early-phase center in Costa Mesa and commercial manufacturing in Tustin.

analytical developmentcell line developmentCGMP clinical manufacturingcGMP commercial manufacturingcontinuous processingdownstream processingfed-batch manufacturingformulation developmentperfusion systemsprocess developmenttech transferupstream processing

Compiled from public sources

BASE PAIR BIOTECHNOLOGIES INC

PEARLAND, TX

Base Pair Biotechnologies, Inc. is an aptamer discovery and development company based in Pearland, TX. It provides custom aptamer discovery and development, multiplex SELEX, bioinformatics for aptamer selection, affinity determination, aptamer maturation, catalog aptamers and reagents, assay development, custom cell culture services, and isothermal titration calorimetry (ITC) binding services.

affinity testingaptamer maturationaptamer selectionassay developmentbacterial cell cultureBioinformaticsBLI affinity testingcell line engineeringisothermal titration calorimetry (ITC)MSTmultiplex SELEXnext-generation sequencingplasmid preparationrecombinant protein expression

Compiled from public sources

BIOFACTURA INC

FREDERICK, MD

BioFactura, Inc. is a clinical-stage biopharmaceutical company based in Frederick, Maryland that develops and manufactures high-value biosimilars, biodefense medical countermeasures, and client-selected novel drugs. Founded in 2004, it leverages its patented StableFast-NS0 Biomanufacturing Platform and CHO expression systems. Programs include biodefense drugs against smallpox and Ebola, novel cancer medicines, and biosimilars for autoimmune and infectious diseases. It launched Capitol Biologics, a CDMO division, in 2025.

analytical assay developmentbioprocess developmentcGMP manufacturingchromatographycontinuous perfusion bioreactor productiondownstream recovery and purificationLC-MS/MS characterizationmanufacturingScale up

Compiled from public sources

Related capabilities

Other processes offered by the shops that list mammalian cell culture.

Browse all capabilities